Tamilan的个人主页 - 老虎社区

Tamilan

Tamilan

காசு பணம் துட்டு மணி

IP属地：未知

3关注

1粉丝

0主题

0勋章

2021-12-17

$SoFi Technologies Inc.(SOFI)$investors sold lot of shares in recent day.. check the company profile column

2021-12-06

As Clover Health Investments, Corp.'s market cap (NASDAQ:CLOV) drops to US$2.0b, insiders might be questioning their decision to buy earlier this year

With Hope and Hype Gone, Clover Health Will Now Remain a Penny Stock

2021-09-29

My one down 20% but thus is still fake news

86Research initiates coverage on TIGR with a BUY rating

2021-12-06

$Clover Health Corp(CLOV)$ we all F***** up As Clover Health Investments, Corp.'s market cap (NASDAQ:CLOV) drops to US$2.0b, insiders might be questioning their decision to buy earlier this year

2022-01-11

‌$Hall of Fame Resort & Entertainment(HOFV)$‌insider buying...HOLD

2021-12-17

Great ariticle, would you like to share it?

@Tamilan:$SoFi Technologies Inc.(SOFI)$investors sold lot of shares in recent day.. check the company profile column

2021-11-26

$Spirit Airlines(SAVE)$ DOES NOT HAVE ANY FLIGHTS TO AFRICA , SO FEAR WILL MAKE MONEY

去老虎APP查看更多动态

{"i18n":{"language":"zh_CN"},"userPageInfo":{"id":3554709228084997,"uuid":"3554709228084997","gmtCreate":1591615249911,"gmtModify":1638581673945,"name":"Tamilan","pinyin":"tamilan","introduction":"","introductionEn":"","signature":"காசு பணம் துட்டு மணி","avatar":"https://static.tigerbbs.com/f9c0c40895d679ae9116bc66aa2adca3","hat":null,"hatId":null,"hatName":null,"vip":1,"status":2,"fanSize":1,"headSize":3,"tweetSize":11,"questionSize":0,"limitLevel":999,"accountStatus":4,"level":{"id":2,"name":"无畏虎","nameTw":"無畏虎","represent":"初生牛犊","factor":"发布3条非转发主帖,1条获得他人回复或点赞","iconColor":"3C9E83","bgColor":"A2F1D9"},"themeCounts":0,"badgeCounts":0,"badges":[],"moderator":false,"superModerator":false,"manageSymbols":null,"badgeLevel":null,"boolIsFan":false,"boolIsHead":false,"favoriteSize":0,"symbols":null,"coverImage":null,"realNameVerified":null,"userBadges":[{"badgeId":"228c86a078844d74991fff2b7ab2428d-3","templateUuid":"228c86a078844d74991fff2b7ab2428d","name":"投资合伙人虎","description":"证券账户累计交易金额达到100万美元","bigImgUrl":"https://static.tigerbbs.com/fbeac6bb240db7da8b972e5183d050ba","smallImgUrl":"https://static.tigerbbs.com/436cdf80292b99f0a992e78750ac4e3a","grayImgUrl":"https://static.tigerbbs.com/506a259a7b456f037592c3b23c779599","redirectLinkEnabled":0,"redirectLink":null,"hasAllocated":1,"isWearing":0,"stamp":null,"stampPosition":0,"hasStamp":0,"allocationCount":1,"allocatedDate":"2021.12.22","exceedPercentage":"93.48%","individualDisplayEnabled":0,"backgroundColor":null,"fontColor":null,"individualDisplaySort":0,"categoryType":1101},{"badgeId":"976c19eed35f4cd78f17501c2e99ef37-1","templateUuid":"976c19eed35f4cd78f17501c2e99ef37","name":"博闻投资者","description":"累计交易超过10只正股","bigImgUrl":"https://static.tigerbbs.com/e74cc24115c4fbae6154ec1b1041bf47","smallImgUrl":"https://static.tigerbbs.com/d48265cbfd97c57f9048db29f22227b0","grayImgUrl":"https://static.tigerbbs.com/76c6d6898b073c77e1c537ebe9ac1c57","redirectLinkEnabled":0,"redirectLink":null,"hasAllocated":1,"isWearing":0,"stamp":null,"stampPosition":0,"hasStamp":0,"allocationCount":1,"allocatedDate":"2021.12.21","exceedPercentage":null,"individualDisplayEnabled":0,"backgroundColor":null,"fontColor":null,"individualDisplaySort":0,"categoryType":1102},{"badgeId":"518b5610c3e8410da5cfad115e4b0f5a-1","templateUuid":"518b5610c3e8410da5cfad115e4b0f5a","name":"实盘交易者","description":"完成一笔实盘交易","bigImgUrl":"https://static.tigerbbs.com/2e08a1cc2087a1de93402c2c290fa65b","smallImgUrl":"https://static.tigerbbs.com/4504a6397ce1137932d56e5f4ce27166","grayImgUrl":"https://static.tigerbbs.com/4b22c79415b4cd6e3d8ebc4a0fa32604","redirectLinkEnabled":0,"redirectLink":null,"hasAllocated":1,"isWearing":0,"stamp":null,"stampPosition":0,"hasStamp":0,"allocationCount":1,"allocatedDate":"2021.12.21","exceedPercentage":null,"individualDisplayEnabled":0,"backgroundColor":null,"fontColor":null,"individualDisplaySort":0,"categoryType":1100},{"badgeId":"35ec162348d5460f88c959321e554969-3","templateUuid":"35ec162348d5460f88c959321e554969","name":"传说交易员","description":"证券或期货账户累计交易次数达到300次","bigImgUrl":"https://static.tigerbbs.com/656db16598a0b8f21429e10d6c1cb033","smallImgUrl":"https://static.tigerbbs.com/03f10910d4dd9234f9b5702a3342193a","grayImgUrl":"https://static.tigerbbs.com/0c767e35268feb729d50d3fa9a386c5a","redirectLinkEnabled":0,"redirectLink":null,"hasAllocated":1,"isWearing":0,"stamp":null,"stampPosition":0,"hasStamp":0,"allocationCount":1,"allocatedDate":"2021.12.21","exceedPercentage":"93.56%","individualDisplayEnabled":0,"backgroundColor":null,"fontColor":null,"individualDisplaySort":0,"categoryType":1100},{"badgeId":"e50ce593bb40487ebfb542ca54f6a561-1","templateUuid":"e50ce593bb40487ebfb542ca54f6a561","name":"出道虎友","description":"加入老虎社区500天","bigImgUrl":"https://static.tigerbbs.com/0e4d0ca1da0456dc7894c946d44bf9ab","smallImgUrl":"https://static.tigerbbs.com/0f2f65e8ce4cfaae8db2bea9b127f58b","grayImgUrl":"https://static.tigerbbs.com/c5948a31b6edf154422335b265235809","redirectLinkEnabled":0,"redirectLink":null,"hasAllocated":1,"isWearing":0,"stamp":null,"stampPosition":0,"hasStamp":0,"allocationCount":1,"allocatedDate":"2021.12.18","exceedPercentage":null,"individualDisplayEnabled":0,"backgroundColor":null,"fontColor":null,"individualDisplaySort":0,"categoryType":1001}],"userBadgeCount":5,"currentWearingBadge":null,"individualDisplayBadges":null,"crmLevel":2,"crmLevelSwitch":0,"location":"未知","starInvestorFollowerNum":0,"starInvestorFlag":false,"starInvestorOrderShareNum":0,"subscribeStarInvestorNum":0,"ror":null,"winRationPercentage":null,"showRor":false,"investmentPhilosophy":null,"starInvestorSubscribeFlag":false},"baikeInfo":{},"tab":"hot","tweets":[{"id":694855893,"gmtCreate":1641914117538,"gmtModify":1641914117643,"author":{"id":"3554709228084997","authorId":"3554709228084997","name":"Tamilan","avatar":"https://static.tigerbbs.com/f9c0c40895d679ae9116bc66aa2adca3","crmLevel":2,"crmLevelSwitch":0,"followedFlag":false},"themes":[],"htmlText":"‌<a href=\"https://laohu8.com/S/HOFV\">$Hall of Fame Resort &amp; Entertainment(HOFV)$</a>‌insider buying...HOLD","listText":"‌<a href=\"https://laohu8.com/S/HOFV\">$Hall of Fame Resort &amp; Entertainment(HOFV)$</a>‌insider buying...HOLD","text":"‌$Hall of Fame Resort & Entertainment(HOFV)$‌insider buying...HOLD","images":[{"img":"https://static.tigerbbs.com/6ca7276796aa05d5c5ddb45f327b6416","width":"200","height":"200"}],"top":1,"highlighted":1,"essential":1,"paper":1,"likeSize":0,"commentSize":0,"repostSize":0,"link":"https://laohu8.com/post/694855893","isVote":1,"tweetType":1,"viewCount":161,"authorTweetTopStatus":1,"verified":2,"comments":[],"imageCount":1,"langContent":"CN","totalScore":0},{"id":690220149,"gmtCreate":1639670607410,"gmtModify":1639670607518,"author":{"id":"3554709228084997","authorId":"3554709228084997","name":"Tamilan","avatar":"https://static.tigerbbs.com/f9c0c40895d679ae9116bc66aa2adca3","crmLevel":2,"crmLevelSwitch":0,"followedFlag":false},"themes":[],"htmlText":"Great ariticle, would you like to share it?","listText":"Great ariticle, would you like to share it?","text":"Great ariticle, would you like to share it?","images":[],"top":1,"highlighted":1,"essential":1,"paper":1,"likeSize":0,"commentSize":0,"repostSize":0,"link":"https://laohu8.com/post/690220149","repostId":"690267465","repostType":1,"repost":{"id":690267465,"gmtCreate":1639670593948,"gmtModify":1639670594054,"author":{"id":"3554709228084997","authorId":"3554709228084997","name":"Tamilan","avatar":"https://static.tigerbbs.com/f9c0c40895d679ae9116bc66aa2adca3","crmLevel":2,"crmLevelSwitch":0,"followedFlag":false},"themes":[],"htmlText":"<a href=\"https://laohu8.com/S/SOFI\">$SoFi Technologies Inc.(SOFI)$</a>investors sold lot of shares in recent day.. check the company profile column&nbsp;","listText":"<a href=\"https://laohu8.com/S/SOFI\">$SoFi Technologies Inc.(SOFI)$</a>investors sold lot of shares in recent day.. check the company profile column&nbsp;","text":"$SoFi Technologies Inc.(SOFI)$investors sold lot of shares in recent day.. check the company profile column","images":[],"top":1,"highlighted":1,"essential":1,"paper":1,"likeSize":0,"commentSize":0,"repostSize":0,"link":"https://laohu8.com/post/690267465","isVote":1,"tweetType":1,"viewCount":0,"authorTweetTopStatus":1,"verified":2,"comments":[],"imageCount":0,"langContent":"CN","totalScore":0},"isVote":1,"tweetType":1,"viewCount":90,"authorTweetTopStatus":1,"verified":2,"comments":[],"imageCount":0,"langContent":"CN","totalScore":0},{"id":690267465,"gmtCreate":1639670593948,"gmtModify":1639670594054,"author":{"id":"3554709228084997","authorId":"3554709228084997","name":"Tamilan","avatar":"https://static.tigerbbs.com/f9c0c40895d679ae9116bc66aa2adca3","crmLevel":2,"crmLevelSwitch":0,"followedFlag":false},"themes":[],"htmlText":"<a href=\"https://laohu8.com/S/SOFI\">$SoFi Technologies Inc.(SOFI)$</a>investors sold lot of shares in recent day.. check the company profile column&nbsp;","listText":"<a href=\"https://laohu8.com/S/SOFI\">$SoFi Technologies Inc.(SOFI)$</a>investors sold lot of shares in recent day.. check the company profile column&nbsp;","text":"$SoFi Technologies Inc.(SOFI)$investors sold lot of shares in recent day.. check the company profile column","images":[],"top":1,"highlighted":1,"essential":1,"paper":1,"likeSize":13,"commentSize":2,"repostSize":1,"link":"https://laohu8.com/post/690267465","isVote":1,"tweetType":1,"viewCount":1814,"authorTweetTopStatus":1,"verified":2,"comments":[],"imageCount":0,"langContent":"CN","totalScore":0},{"id":606003855,"gmtCreate":1638797908762,"gmtModify":1638799926288,"author":{"id":"3554709228084997","authorId":"3554709228084997","name":"Tamilan","avatar":"https://static.tigerbbs.com/f9c0c40895d679ae9116bc66aa2adca3","crmLevel":2,"crmLevelSwitch":0,"followedFlag":false},"themes":[],"htmlText":"As Clover Health Investments, Corp.'s market cap (NASDAQ:CLOV) drops to US$2.0b, insiders might be questioning their decision to buy earlier this year","listText":"As Clover Health Investments, Corp.'s market cap (NASDAQ:CLOV) drops to US$2.0b, insiders might be questioning their decision to buy earlier this year","text":"As Clover Health Investments, Corp.'s market cap (NASDAQ:CLOV) drops to US$2.0b, insiders might be questioning their decision to buy earlier this year","images":[],"top":1,"highlighted":1,"essential":1,"paper":1,"likeSize":3,"commentSize":0,"repostSize":0,"link":"https://laohu8.com/post/606003855","repostId":"1147959487","repostType":2,"repost":{"id":"1147959487","pubTimestamp":1638793685,"share":"https://www.laohu8.com/m/news/1147959487?lang=&edition=full","pubTime":"2021-12-06 20:28","market":"us","language":"en","title":"With Hope and Hype Gone, Clover Health Will Now Remain a Penny Stock","url":"https://stock-news.laohu8.com/highlight/detail?id=1147959487","media":"InvestorPlace","summary":"As it struggles to control costs, don't expect continued top-line growth to fuel a recovery for CLOV","content":"<p>As it struggles to control costs, don't expect continued top-line growth to fuel a recovery for CLOV stock</p>\n<p>I may have&nbsp;called it one ahead of time. But now, after it’s slipped below $5 per share,<b>Clover Health</b>(NASDAQ:<b><u>CLOV</u></b>) is officially a penny stock. Sure, this label says little about the prospects for CLOV stock, or its underlying business. Yet there is one key takeaway. The hope and hype surrounding this online-based provider of Medicare Advantage plans is officially gone.</p>\n<p>As you likely recall, there have been several waves of enthusiasm surrounding this stock over the past year. First, after this special purpose acquisition company (SPAC) deSPACed in late 2020, investors bid it up. Given the success of other blank-check companies backed by Chamath Palihapitiya, this made sense.</p>\n<p>Then, after falling sharply between February and May, due to a&nbsp;“short report”&nbsp;and the&nbsp;“SPAC wipeout,”the stock became hot once again.</p>\n<p>This time, as a meme stock/short-squeeze play going parabolic and hitting new highs, Clover almost seemed set to join the ranks of&nbsp;<b>AMC Entertainment</b>(NYSE:<b><u>AMC</u></b>) and&nbsp;<b>GameStop</b>(NYSE:<b><u>GME</u></b>). But it didn’t. After June, it steadily became less of a squeeze play. Over the past six months, its short interest has gone from off-the-charts, to just&nbsp;7.6% of outstanding float.</p>\n<p>Today, with conversation about it on&nbsp;<b>Reddit’s</b><i>r/WallStreetsBets</i>&nbsp;subreddit&nbsp;well subdued fro what it once was, there’s only one path for shares out of their current penny stock status. Unfortunately, it’s a long one.</p>\n<p><b>Why CLOV Stock Fell Below $5 Per Share</b></p>\n<p>You can try to argue that Clover Health’s move to below $5 per share is due solely to market volatility. News of Covid-19’s Omicron variant, plus hawkish remarks from the Federal Reserve, have caused&nbsp;stocks across-the-board to move lower.</p>\n<p>But even before the latest overall dip in the market, CLOV stock was already heading south. Blame that on its latest quarterly earnings report, and&nbsp;sell side’s pessimism about its profitability&nbsp;timeline. Plus, as my&nbsp;<i>InvestorPlace</i>&nbsp;colleague Joel Baglole discussed on Nov. 18, there’s its recent dilutive&nbsp;$300 million secondary offering.</p>\n<p>On top of this, news of&nbsp; a&nbsp;shareholder lawsuit,due to Clover allegedly not disclosing the open Department of Justice (DOJ) investigation of it, which was one of the key bombshells from the above-mentioned short report. This grab bag of company-specific developments came on top of another key negative for the stock. That would be its waning appeal among the meme crowd. After several failed attempts to send it “to the moon” once more, Reddit traders have moved on.</p>\n<p>Put all these factors together, and it is clear why Clover now finds itself in the bargain basement.</p>\n<p>Yet, there is a silver lining. If it can get its operating costs under control, it will then start moving again in the right direction. The problem? For now, there’s little to suggest that’s soon set to happen.</p>\n<p><b>Only Cheap if You Assume Profitability Is Imminent</b></p>\n<p>Yes, at the current CLOV stock price (around $4.47 per share), it’s obviously not as pricey as it was at $10, $15, $20 or even $28.85 per share. Trading for less than 1x projected sales for 2022, this “disruptor” now trades at a forward valuation more in-line with its old-school peers.</p>\n<p>Furthermore, as my<i>InvestorPlace</i>colleague Dana Blankenhorn recently argued, if Clover managed to bring its margins up on par with&nbsp;<b>UnitedHealth Group</b>&nbsp;(NYSE:<b><u>UNH</u></b>) by next year, shares would be selling for just&nbsp;15x forward earnings. Unfortunately, bringing up margins is easier said than done.</p>\n<p>To achieve this, several things need to play out. First, Clover’s thesis that its very high&nbsp;medical cost ratio(MCR) is “transitory,” and a product of increased healthcare usage due to the pandemic recovery, needs to prove true. If a few quarters from now, when things have normalized post-Covid, the company is still paying out more in claims than it’s taking in as premiums? It’s going to be much harder for it to blame the virus for its problems.</p>\n<p>Second, even if it brings its MCR down to 85% (the bare minimum it needs to spend each year), it will need to really ramp up sales to cover its fixed overhead costs. Based on its SG&amp;A expenses last quarter ($119.1 million), its annual overhead is around $476.4 million. If it managed to achieve gross margins of 15%, it would need to generate at least $3.17 billion in revenue next year. Sell-side projections call for&nbsp;between $2.48 billion and $2.92 billion&nbsp;in revenue next year.</p>\n<p><b>Bottom Line on Clover</b></p>\n<p>I concede that it’s not impossible for Clover to one day become profitable. Assuming it continues to grow its revenues by high double-digits.&nbsp; The issue is with the timeline. Between now and when it gets out of the red, it could stay stuck at present levels, as more dilutive secondary offerings (to cover cash burn/fund growth) impact its ability to bounce back.</p>\n<p>Likely to languish at or below $5 per share for a while, skip out for now with CLOV stock.</p>","source":"lsy1606302653667","collect":0,"html":"<!DOCTYPE html>\n<html>\n<head>\n<meta http-equiv=\"Content-Type\" content=\"text/html; charset=utf-8\" />\n<meta name=\"viewport\" content=\"width=device-width,initial-scale=1.0,minimum-scale=1.0,maximum-scale=1.0,user-scalable=no\"/>\n<meta name=\"format-detection\" content=\"telephone=no,email=no,address=no\" />\n<title>With Hope and Hype Gone, Clover Health Will Now Remain a Penny Stock</title>\n<style type=\"text/css\">\na,abbr,acronym,address,applet,article,aside,audio,b,big,blockquote,body,canvas,caption,center,cite,code,dd,del,details,dfn,div,dl,dt,\nem,embed,fieldset,figcaption,figure,footer,form,h1,h2,h3,h4,h5,h6,header,hgroup,html,i,iframe,img,ins,kbd,label,legend,li,mark,menu,nav,\nobject,ol,output,p,pre,q,ruby,s,samp,section,small,span,strike,strong,sub,summary,sup,table,tbody,td,tfoot,th,thead,time,tr,tt,u,ul,var,video{ font:inherit;margin:0;padding:0;vertical-align:baseline;border:0 }\nbody{ font-size:16px; line-height:1.5; color:#999; background:transparent; }\n.wrapper{ overflow:hidden;word-break:break-all;padding:10px; }\nh1,h2{ font-weight:normal; line-height:1.35; margin-bottom:.6em; }\nh3,h4,h5,h6{ line-height:1.35; margin-bottom:1em; }\nh1{ font-size:24px; }\nh2{ font-size:20px; }\nh3{ font-size:18px; }\nh4{ font-size:16px; }\nh5{ font-size:14px; }\nh6{ font-size:12px; }\np,ul,ol,blockquote,dl,table{ margin:1.2em 0; }\nul,ol{ margin-left:2em; }\nul{ list-style:disc; }\nol{ list-style:decimal; }\nli,li p{ margin:10px 0;}\nimg{ max-width:100%;display:block;margin:0 auto 1em; }\nblockquote{ color:#B5B2B1; border-left:3px solid #aaa; padding:1em; }\nstrong,b{font-weight:bold;}\nem,i{font-style:italic;}\ntable{ width:100%;border-collapse:collapse;border-spacing:1px;margin:1em 0;font-size:.9em; }\nth,td{ padding:5px;text-align:left;border:1px solid #aaa; }\nth{ font-weight:bold;background:#5d5d5d; }\n.symbol-link{font-weight:bold;}\n/* header{ border-bottom:1px solid #494756; } */\n.title{ margin:0 0 8px;line-height:1.3;color:#ddd; }\n.meta {color:#5e5c6d;font-size:13px;margin:0 0 .5em; }\na{text-decoration:none; color:#2a4b87;}\n.meta .head { display: inline-block; overflow: hidden}\n.head .h-thumb { width: 30px; height: 30px; margin: 0; padding: 0; border-radius: 50%; float: left;}\n.head .h-content { margin: 0; padding: 0 0 0 9px; float: left;}\n.head .h-name {font-size: 13px; color: #eee; margin: 0;}\n.head .h-time {font-size: 11px; color: #7E829C; margin: 0;line-height: 11px;}\n.small {font-size: 12.5px; display: inline-block; transform: scale(0.9); -webkit-transform: scale(0.9); transform-origin: left; -webkit-transform-origin: left;}\n.smaller {font-size: 12.5px; display: inline-block; transform: scale(0.8); -webkit-transform: scale(0.8); transform-origin: left; -webkit-transform-origin: left;}\n.bt-text {font-size: 12px;margin: 1.5em 0 0 0}\n.bt-text p {margin: 0}\n</style>\n</head>\n<body>\n<div class=\"wrapper\">\n<header>\n<h2 class=\"title\">\nWith Hope and Hype Gone, Clover Health Will Now Remain a Penny Stock\n</h2>\n\n<h4 class=\"meta\">\n\n\n2021-12-06 20:28 GMT+8&nbsp;&nbsp;&nbsp;<a href=https://investorplace.com/2021/12/clov-stock-now-penny-stock-expect-it-to-stay-that-way/><strong>InvestorPlace</strong></a>\n\n\n</h4>\n\n</header>\n<article>\n<div>\n<p>As it struggles to control costs, don't expect continued top-line growth to fuel a recovery for CLOV stock\nI may have called it one ahead of time. But now, after it’s slipped below $5 per share,Clover...</p>\n\n<a href=\"https://investorplace.com/2021/12/clov-stock-now-penny-stock-expect-it-to-stay-that-way/\">Web Link</a>\n\n</div>\n\n\n</article>\n</div>\n</body>\n</html>\n","type":0,"thumbnail":"","relate_stocks":{"CLOV":"Clover Health Corp"},"source_url":"https://investorplace.com/2021/12/clov-stock-now-penny-stock-expect-it-to-stay-that-way/","is_english":true,"share_image_url":"https://static.laohu8.com/e9f99090a1c2ed51c021029395664489","article_id":"1147959487","content_text":"As it struggles to control costs, don't expect continued top-line growth to fuel a recovery for CLOV stock\nI may have called it one ahead of time. But now, after it’s slipped below $5 per share,Clover Health(NASDAQ:CLOV) is officially a penny stock. Sure, this label says little about the prospects for CLOV stock, or its underlying business. Yet there is one key takeaway. The hope and hype surrounding this online-based provider of Medicare Advantage plans is officially gone.\nAs you likely recall, there have been several waves of enthusiasm surrounding this stock over the past year. First, after this special purpose acquisition company (SPAC) deSPACed in late 2020, investors bid it up. Given the success of other blank-check companies backed by Chamath Palihapitiya, this made sense.\nThen, after falling sharply between February and May, due to a “short report” and the “SPAC wipeout,”the stock became hot once again.\nThis time, as a meme stock/short-squeeze play going parabolic and hitting new highs, Clover almost seemed set to join the ranks of AMC Entertainment(NYSE:AMC) and GameStop(NYSE:GME). But it didn’t. After June, it steadily became less of a squeeze play. Over the past six months, its short interest has gone from off-the-charts, to just 7.6% of outstanding float.\nToday, with conversation about it on Reddit’sr/WallStreetsBets subreddit well subdued fro what it once was, there’s only one path for shares out of their current penny stock status. Unfortunately, it’s a long one.\nWhy CLOV Stock Fell Below $5 Per Share\nYou can try to argue that Clover Health’s move to below $5 per share is due solely to market volatility. News of Covid-19’s Omicron variant, plus hawkish remarks from the Federal Reserve, have caused stocks across-the-board to move lower.\nBut even before the latest overall dip in the market, CLOV stock was already heading south. Blame that on its latest quarterly earnings report, and sell side’s pessimism about its profitability timeline. Plus, as my InvestorPlace colleague Joel Baglole discussed on Nov. 18, there’s its recent dilutive $300 million secondary offering.\nOn top of this, news of  a shareholder lawsuit,due to Clover allegedly not disclosing the open Department of Justice (DOJ) investigation of it, which was one of the key bombshells from the above-mentioned short report. This grab bag of company-specific developments came on top of another key negative for the stock. That would be its waning appeal among the meme crowd. After several failed attempts to send it “to the moon” once more, Reddit traders have moved on.\nPut all these factors together, and it is clear why Clover now finds itself in the bargain basement.\nYet, there is a silver lining. If it can get its operating costs under control, it will then start moving again in the right direction. The problem? For now, there’s little to suggest that’s soon set to happen.\nOnly Cheap if You Assume Profitability Is Imminent\nYes, at the current CLOV stock price (around $4.47 per share), it’s obviously not as pricey as it was at $10, $15, $20 or even $28.85 per share. Trading for less than 1x projected sales for 2022, this “disruptor” now trades at a forward valuation more in-line with its old-school peers.\nFurthermore, as myInvestorPlacecolleague Dana Blankenhorn recently argued, if Clover managed to bring its margins up on par with UnitedHealth Group (NYSE:UNH) by next year, shares would be selling for just 15x forward earnings. Unfortunately, bringing up margins is easier said than done.\nTo achieve this, several things need to play out. First, Clover’s thesis that its very high medical cost ratio(MCR) is “transitory,” and a product of increased healthcare usage due to the pandemic recovery, needs to prove true. If a few quarters from now, when things have normalized post-Covid, the company is still paying out more in claims than it’s taking in as premiums? It’s going to be much harder for it to blame the virus for its problems.\nSecond, even if it brings its MCR down to 85% (the bare minimum it needs to spend each year), it will need to really ramp up sales to cover its fixed overhead costs. Based on its SG&A expenses last quarter ($119.1 million), its annual overhead is around $476.4 million. If it managed to achieve gross margins of 15%, it would need to generate at least $3.17 billion in revenue next year. Sell-side projections call for between $2.48 billion and $2.92 billion in revenue next year.\nBottom Line on Clover\nI concede that it’s not impossible for Clover to one day become profitable. Assuming it continues to grow its revenues by high double-digits.  The issue is with the timeline. Between now and when it gets out of the red, it could stay stuck at present levels, as more dilutive secondary offerings (to cover cash burn/fund growth) impact its ability to bounce back.\nLikely to languish at or below $5 per share for a while, skip out for now with CLOV stock.","news_type":1},"isVote":1,"tweetType":1,"viewCount":461,"authorTweetTopStatus":1,"verified":2,"comments":[],"imageCount":0,"langContent":"CN","totalScore":0},{"id":606003908,"gmtCreate":1638797893312,"gmtModify":1638799926250,"author":{"id":"3554709228084997","authorId":"3554709228084997","name":"Tamilan","avatar":"https://static.tigerbbs.com/f9c0c40895d679ae9116bc66aa2adca3","crmLevel":2,"crmLevelSwitch":0,"followedFlag":false},"themes":[],"htmlText":"<a target=\"_blank\" href=\"https://laohu8.com/S/CLOV\">$Clover Health Corp(CLOV)$</a> we all F***** up As Clover Health Investments, Corp.'s market cap (NASDAQ:CLOV) drops to US$2.0b, insiders might be questioning their decision to buy earlier this year","listText":"<a target=\"_blank\" href=\"https://laohu8.com/S/CLOV\">$Clover Health Corp(CLOV)$</a> we all F***** up As Clover Health Investments, Corp.'s market cap (NASDAQ:CLOV) drops to US$2.0b, insiders might be questioning their decision to buy earlier this year","text":"$Clover Health Corp(CLOV)$ we all F***** up As Clover Health Investments, Corp.'s market cap (NASDAQ:CLOV) drops to US$2.0b, insiders might be questioning their decision to buy earlier this year","images":[],"top":1,"highlighted":1,"essential":1,"paper":1,"likeSize":1,"commentSize":0,"repostSize":0,"link":"https://laohu8.com/post/606003908","isVote":1,"tweetType":1,"viewCount":693,"authorTweetTopStatus":1,"verified":2,"comments":[],"imageCount":0,"langContent":"CN","totalScore":0},{"id":877210807,"gmtCreate":1637934743066,"gmtModify":1637934743066,"author":{"id":"3554709228084997","authorId":"3554709228084997","name":"Tamilan","avatar":"https://static.tigerbbs.com/f9c0c40895d679ae9116bc66aa2adca3","crmLevel":2,"crmLevelSwitch":0,"followedFlag":false},"themes":[],"htmlText":"<a target=\"_blank\" href=\"https://laohu8.com/S/SAVE\">$Spirit Airlines(SAVE)$</a> DOES NOT HAVE ANY FLIGHTS TO AFRICA , SO FEAR WILL MAKE MONEY","listText":"<a target=\"_blank\" href=\"https://laohu8.com/S/SAVE\">$Spirit Airlines(SAVE)$</a> DOES NOT HAVE ANY FLIGHTS TO AFRICA , SO FEAR WILL MAKE MONEY","text":"$Spirit Airlines(SAVE)$ DOES NOT HAVE ANY FLIGHTS TO AFRICA , SO FEAR WILL MAKE MONEY","images":[],"top":1,"highlighted":1,"essential":1,"paper":1,"likeSize":0,"commentSize":0,"repostSize":0,"link":"https://laohu8.com/post/877210807","isVote":1,"tweetType":1,"viewCount":500,"authorTweetTopStatus":1,"verified":2,"comments":[],"imageCount":0,"langContent":"CN","totalScore":0},{"id":865010843,"gmtCreate":1632923246605,"gmtModify":1632923246672,"author":{"id":"3554709228084997","authorId":"3554709228084997","name":"Tamilan","avatar":"https://static.tigerbbs.com/f9c0c40895d679ae9116bc66aa2adca3","crmLevel":2,"crmLevelSwitch":0,"followedFlag":false},"themes":[],"htmlText":"My one down 20% but thus is still fake news&nbsp;","listText":"My one down 20% but thus is still fake news&nbsp;","text":"My one down 20% but thus is still fake news","images":[],"top":1,"highlighted":1,"essential":1,"paper":1,"likeSize":2,"commentSize":0,"repostSize":0,"link":"https://laohu8.com/post/865010843","repostId":"1169529009","repostType":2,"repost":{"id":"1169529009","weMediaInfo":{"introduction":"Providing stock market headlines, business news, financials and earnings ","home_visible":1,"media_name":"Tiger Newspress","id":"1079075236","head_image":"https://static.tigerbbs.com/8274c5b9d4c2852bfb1c4d6ce16c68ba"},"pubTimestamp":1632904196,"share":"https://www.laohu8.com/m/news/1169529009?lang=&edition=full","pubTime":"2021-09-29 16:29","market":"us","language":"en","title":"86Research initiates coverage on TIGR with a BUY rating","url":"https://stock-news.laohu8.com/highlight/detail?id=1169529009","media":"Tiger Newspress","summary":"• 86Research initiates coverage on TIGR with a BUY rating. Growing demand for cross-border stock inv","content":"<p>• 86Research initiates coverage on TIGR with a BUY rating. Growing demand for cross-border stock investment in China and rising internet-based retail brokerage services globally&nbsp;together support strong industry fundamentals. TIGR, an early mover in the internet brokerage sector, significantly outperforms traditional brokers by providing better services for retail investors. Their&nbsp;price target of US$21 per ADS implies 83%&nbsp;upside&nbsp;potential&nbsp;from&nbsp;the&nbsp;latest&nbsp;market&nbsp;close&nbsp;price,&nbsp;despite&nbsp;possible&nbsp;sector-widevolatilityinChineseADRs.</p>\n<p>•&nbsp;86Research forecasts TIGR’s net revenues will reach US&nbsp;$668 mln in 2024, giving it a 4-yr CAGR of 51%. According to their projection, the number of customers with deposits on TIGR will reach 1.7 mln by the end of 2024. The total AUM and financing balance will exceed US$103 bln and US$5.5 bln, respectively. Trading volumes on TIGR are forecast to reach US$1,338 bln in 2024. 86Research expects the commission rate will remain largely flat. More derivatives trades will partially offset the negative impact from price competition. 86Research thinks the blended interest rate will&nbsp;decline&nbsp;due&nbsp;to&nbsp;the&nbsp;mix&nbsp;change&nbsp;of&nbsp;financing&nbsp;activities&nbsp;on&nbsp;the&nbsp;platform.</p>\n<p>• 86Research&nbsp;derives&nbsp;their&nbsp;US$21&nbsp;price&nbsp;target&nbsp;based&nbsp;on&nbsp;a&nbsp;20x&nbsp;2024E&nbsp;P/E&nbsp;multiple&nbsp;and&nbsp;13%&nbsp;2-yr&nbsp;discount&nbsp;rate.&nbsp;The&nbsp;PT&nbsp;implies&nbsp;13.8x/11.7x/8.4x&nbsp;2021E/2022E/2023E&nbsp;forward&nbsp;P/B&nbsp;multiples,&nbsp;reflecting&nbsp;a&nbsp;premium&nbsp;to&nbsp;global&nbsp;peers.&nbsp;HK&nbsp;license&nbsp;approval,&nbsp;progress&nbsp;in&nbsp;international&nbsp;expansion and US self-clearing are the key catalysts in the near term, while regulatory and macro uncertainties are the main investment risks. 86Research recommends investors buy the stock on recent pullbacks which have resulted from weak market sentiment. 86’s View on TIGR: BUY; PT$21/ADS; A Rising China-Based Internet Brokerage Platform; Global Expansion To Drive Long-term Growth; Recent pullbacks create a buying opportunity.</p>\n<p>• 86Research is bullish on TIGR’s capability to continue to gain market share from traditional brokers. The strategic focus and operating efficiency of Internet companies give advantages to TIGR, such as lower pricing and better user experience in retail brokerage services. Moreover, TIGR provides more variety than most traditional brokers, enabling retail investors to trade securities in several markets in one app&nbsp;and&nbsp;one&nbsp;account.</p>\n<p>• Non-commission revenues are ramping up quickly. Interest income will keep growing as more consolidated account (CA) account users will adopt self-funded financing services provided by TIGR. Their analysis suggests that the net interest spread of the financing services for CA account users was much higher than the rate of financing service for fully disclosed (FD) account users. In addition, the business&nbsp;development&nbsp;in&nbsp;investment&nbsp;banking&nbsp;and&nbsp;wealth&nbsp;management&nbsp;services&nbsp;are&nbsp;expected&nbsp;to&nbsp;contribute&nbsp;meaningful&nbsp;revenues.</p>\n<p>• International expansion creates a new story. TIGR has ramped up its global expansion from 3Q20, mainly targeting Singapore and US markets. Singapore has more than 1 mln addressable individual investors, about half of the market size in HK. The US market has nearly 100 mln retail investors, with total assets of approximately $50 trillion.&nbsp;Although&nbsp;facing&nbsp;challenges&nbsp;in&nbsp;terms&nbsp;of&nbsp;culture,&nbsp;regulatory&nbsp;environment&nbsp;and&nbsp;competition,&nbsp;86Research&nbsp;is&nbsp;positive&nbsp;that&nbsp;TIGR&nbsp;will&nbsp;capture&nbsp;more&nbsp;growth&nbsp;in&nbsp;its&nbsp;two&nbsp;promising&nbsp;markets.</p>\n<p>• TIGR’s stock price has been volatile. 86Research recommends investors buy on the dip. Recent stock market volatility will impact its financial performance but won‘t change the long-term growth story, in their view. The company continues to gain market share in retail brokerage services and develop non-commission businesses, such as margin financing, wealth management, order flows, etc.86Research&nbsp;is confident such growth&nbsp;can&nbsp;offset&nbsp;the&nbsp;cyclical&nbsp;impact&nbsp;from&nbsp;a&nbsp;long-term&nbsp;perspective.</p>\n<p>• HK license is a near-term catalyst. TIGR is expected to get a brokerage license in HK as soon as this year, which will enable it to run market campaigns and acquire users in the region. As a registered brokerage firm, TIGR&nbsp;can&nbsp;also&nbsp;build&nbsp;connections&nbsp;with&nbsp;banks to&nbsp;provide&nbsp;IPO&nbsp;subscriptions&nbsp;and&nbsp;financing&nbsp;services&nbsp;in&nbsp;Hong&nbsp;Kong&nbsp;and&nbsp;support&nbsp;the&nbsp;development&nbsp;of&nbsp;margin&nbsp;financing&nbsp;business.</p>","collect":0,"html":"<!DOCTYPE html>\n<html>\n<head>\n<meta http-equiv=\"Content-Type\" content=\"text/html; charset=utf-8\" />\n<meta name=\"viewport\" content=\"width=device-width,initial-scale=1.0,minimum-scale=1.0,maximum-scale=1.0,user-scalable=no\"/>\n<meta name=\"format-detection\" content=\"telephone=no,email=no,address=no\" />\n<title>86Research initiates coverage on TIGR with a BUY rating</title>\n<style type=\"text/css\">\na,abbr,acronym,address,applet,article,aside,audio,b,big,blockquote,body,canvas,caption,center,cite,code,dd,del,details,dfn,div,dl,dt,\nem,embed,fieldset,figcaption,figure,footer,form,h1,h2,h3,h4,h5,h6,header,hgroup,html,i,iframe,img,ins,kbd,label,legend,li,mark,menu,nav,\nobject,ol,output,p,pre,q,ruby,s,samp,section,small,span,strike,strong,sub,summary,sup,table,tbody,td,tfoot,th,thead,time,tr,tt,u,ul,var,video{ font:inherit;margin:0;padding:0;vertical-align:baseline;border:0 }\nbody{ font-size:16px; line-height:1.5; color:#999; background:transparent; }\n.wrapper{ overflow:hidden;word-break:break-all;padding:10px; }\nh1,h2{ font-weight:normal; line-height:1.35; margin-bottom:.6em; }\nh3,h4,h5,h6{ line-height:1.35; margin-bottom:1em; }\nh1{ font-size:24px; }\nh2{ font-size:20px; }\nh3{ font-size:18px; }\nh4{ font-size:16px; }\nh5{ font-size:14px; }\nh6{ font-size:12px; }\np,ul,ol,blockquote,dl,table{ margin:1.2em 0; }\nul,ol{ margin-left:2em; }\nul{ list-style:disc; }\nol{ list-style:decimal; }\nli,li p{ margin:10px 0;}\nimg{ max-width:100%;display:block;margin:0 auto 1em; }\nblockquote{ color:#B5B2B1; border-left:3px solid #aaa; padding:1em; }\nstrong,b{font-weight:bold;}\nem,i{font-style:italic;}\ntable{ width:100%;border-collapse:collapse;border-spacing:1px;margin:1em 0;font-size:.9em; }\nth,td{ padding:5px;text-align:left;border:1px solid #aaa; }\nth{ font-weight:bold;background:#5d5d5d; }\n.symbol-link{font-weight:bold;}\n/* header{ border-bottom:1px solid #494756; } */\n.title{ margin:0 0 8px;line-height:1.3;color:#ddd; }\n.meta {color:#5e5c6d;font-size:13px;margin:0 0 .5em; }\na{text-decoration:none; color:#2a4b87;}\n.meta .head { display: inline-block; overflow: hidden}\n.head .h-thumb { width: 30px; height: 30px; margin: 0; padding: 0; border-radius: 50%; float: left;}\n.head .h-content { margin: 0; padding: 0 0 0 9px; float: left;}\n.head .h-name {font-size: 13px; color: #eee; margin: 0;}\n.head .h-time {font-size: 11px; color: #7E829C; margin: 0;line-height: 11px;}\n.small {font-size: 12.5px; display: inline-block; transform: scale(0.9); -webkit-transform: scale(0.9); transform-origin: left; -webkit-transform-origin: left;}\n.smaller {font-size: 12.5px; display: inline-block; transform: scale(0.8); -webkit-transform: scale(0.8); transform-origin: left; -webkit-transform-origin: left;}\n.bt-text {font-size: 12px;margin: 1.5em 0 0 0}\n.bt-text p {margin: 0}\n</style>\n</head>\n<body>\n<div class=\"wrapper\">\n<header>\n<h2 class=\"title\">\n86Research initiates coverage on TIGR with a BUY rating\n</h2>\n\n<h4 class=\"meta\">\n\n\n<a class=\"head\" href=\"https://laohu8.com/wemedia/1079075236\">\n\n\n<div class=\"h-thumb\" style=\"background-image:url(https://static.tigerbbs.com/8274c5b9d4c2852bfb1c4d6ce16c68ba);background-size:cover;\"></div>\n\n<div class=\"h-content\">\n<p class=\"h-name\">Tiger Newspress </p>\n<p class=\"h-time\">2021-09-29 16:29</p>\n</div>\n\n</a>\n\n\n</h4>\n\n</header>\n<article>\n<p>• 86Research initiates coverage on TIGR with a BUY rating. Growing demand for cross-border stock investment in China and rising internet-based retail brokerage services globally&nbsp;together support strong industry fundamentals. TIGR, an early mover in the internet brokerage sector, significantly outperforms traditional brokers by providing better services for retail investors. Their&nbsp;price target of US$21 per ADS implies 83%&nbsp;upside&nbsp;potential&nbsp;from&nbsp;the&nbsp;latest&nbsp;market&nbsp;close&nbsp;price,&nbsp;despite&nbsp;possible&nbsp;sector-widevolatilityinChineseADRs.</p>\n<p>•&nbsp;86Research forecasts TIGR’s net revenues will reach US&nbsp;$668 mln in 2024, giving it a 4-yr CAGR of 51%. According to their projection, the number of customers with deposits on TIGR will reach 1.7 mln by the end of 2024. The total AUM and financing balance will exceed US$103 bln and US$5.5 bln, respectively. Trading volumes on TIGR are forecast to reach US$1,338 bln in 2024. 86Research expects the commission rate will remain largely flat. More derivatives trades will partially offset the negative impact from price competition. 86Research thinks the blended interest rate will&nbsp;decline&nbsp;due&nbsp;to&nbsp;the&nbsp;mix&nbsp;change&nbsp;of&nbsp;financing&nbsp;activities&nbsp;on&nbsp;the&nbsp;platform.</p>\n<p>• 86Research&nbsp;derives&nbsp;their&nbsp;US$21&nbsp;price&nbsp;target&nbsp;based&nbsp;on&nbsp;a&nbsp;20x&nbsp;2024E&nbsp;P/E&nbsp;multiple&nbsp;and&nbsp;13%&nbsp;2-yr&nbsp;discount&nbsp;rate.&nbsp;The&nbsp;PT&nbsp;implies&nbsp;13.8x/11.7x/8.4x&nbsp;2021E/2022E/2023E&nbsp;forward&nbsp;P/B&nbsp;multiples,&nbsp;reflecting&nbsp;a&nbsp;premium&nbsp;to&nbsp;global&nbsp;peers.&nbsp;HK&nbsp;license&nbsp;approval,&nbsp;progress&nbsp;in&nbsp;international&nbsp;expansion and US self-clearing are the key catalysts in the near term, while regulatory and macro uncertainties are the main investment risks. 86Research recommends investors buy the stock on recent pullbacks which have resulted from weak market sentiment. 86’s View on TIGR: BUY; PT$21/ADS; A Rising China-Based Internet Brokerage Platform; Global Expansion To Drive Long-term Growth; Recent pullbacks create a buying opportunity.</p>\n<p>• 86Research is bullish on TIGR’s capability to continue to gain market share from traditional brokers. The strategic focus and operating efficiency of Internet companies give advantages to TIGR, such as lower pricing and better user experience in retail brokerage services. Moreover, TIGR provides more variety than most traditional brokers, enabling retail investors to trade securities in several markets in one app&nbsp;and&nbsp;one&nbsp;account.</p>\n<p>• Non-commission revenues are ramping up quickly. Interest income will keep growing as more consolidated account (CA) account users will adopt self-funded financing services provided by TIGR. Their analysis suggests that the net interest spread of the financing services for CA account users was much higher than the rate of financing service for fully disclosed (FD) account users. In addition, the business&nbsp;development&nbsp;in&nbsp;investment&nbsp;banking&nbsp;and&nbsp;wealth&nbsp;management&nbsp;services&nbsp;are&nbsp;expected&nbsp;to&nbsp;contribute&nbsp;meaningful&nbsp;revenues.</p>\n<p>• International expansion creates a new story. TIGR has ramped up its global expansion from 3Q20, mainly targeting Singapore and US markets. Singapore has more than 1 mln addressable individual investors, about half of the market size in HK. The US market has nearly 100 mln retail investors, with total assets of approximately $50 trillion.&nbsp;Although&nbsp;facing&nbsp;challenges&nbsp;in&nbsp;terms&nbsp;of&nbsp;culture,&nbsp;regulatory&nbsp;environment&nbsp;and&nbsp;competition,&nbsp;86Research&nbsp;is&nbsp;positive&nbsp;that&nbsp;TIGR&nbsp;will&nbsp;capture&nbsp;more&nbsp;growth&nbsp;in&nbsp;its&nbsp;two&nbsp;promising&nbsp;markets.</p>\n<p>• TIGR’s stock price has been volatile. 86Research recommends investors buy on the dip. Recent stock market volatility will impact its financial performance but won‘t change the long-term growth story, in their view. The company continues to gain market share in retail brokerage services and develop non-commission businesses, such as margin financing, wealth management, order flows, etc.86Research&nbsp;is confident such growth&nbsp;can&nbsp;offset&nbsp;the&nbsp;cyclical&nbsp;impact&nbsp;from&nbsp;a&nbsp;long-term&nbsp;perspective.</p>\n<p>• HK license is a near-term catalyst. TIGR is expected to get a brokerage license in HK as soon as this year, which will enable it to run market campaigns and acquire users in the region. As a registered brokerage firm, TIGR&nbsp;can&nbsp;also&nbsp;build&nbsp;connections&nbsp;with&nbsp;banks to&nbsp;provide&nbsp;IPO&nbsp;subscriptions&nbsp;and&nbsp;financing&nbsp;services&nbsp;in&nbsp;Hong&nbsp;Kong&nbsp;and&nbsp;support&nbsp;the&nbsp;development&nbsp;of&nbsp;margin&nbsp;financing&nbsp;business.</p>\n\n</article>\n</div>\n</body>\n</html>\n","type":0,"thumbnail":"","relate_stocks":{"TIGR":"老虎证券"},"is_english":true,"share_image_url":"https://static.laohu8.com/e9f99090a1c2ed51c021029395664489","article_id":"1169529009","content_text":"• 86Research initiates coverage on TIGR with a BUY rating. Growing demand for cross-border stock investment in China and rising internet-based retail brokerage services globally together support strong industry fundamentals. TIGR, an early mover in the internet brokerage sector, significantly outperforms traditional brokers by providing better services for retail investors. Their price target of US$21 per ADS implies 83% upside potential from the latest market close price, despite possible sector-widevolatilityinChineseADRs.\n• 86Research forecasts TIGR’s net revenues will reach US $668 mln in 2024, giving it a 4-yr CAGR of 51%. According to their projection, the number of customers with deposits on TIGR will reach 1.7 mln by the end of 2024. The total AUM and financing balance will exceed US$103 bln and US$5.5 bln, respectively. Trading volumes on TIGR are forecast to reach US$1,338 bln in 2024. 86Research expects the commission rate will remain largely flat. More derivatives trades will partially offset the negative impact from price competition. 86Research thinks the blended interest rate will decline due to the mix change of financing activities on the platform.\n• 86Research derives their US$21 price target based on a 20x 2024E P/E multiple and 13% 2-yr discount rate. The PT implies 13.8x/11.7x/8.4x 2021E/2022E/2023E forward P/B multiples, reflecting a premium to global peers. HK license approval, progress in international expansion and US self-clearing are the key catalysts in the near term, while regulatory and macro uncertainties are the main investment risks. 86Research recommends investors buy the stock on recent pullbacks which have resulted from weak market sentiment. 86’s View on TIGR: BUY; PT$21/ADS; A Rising China-Based Internet Brokerage Platform; Global Expansion To Drive Long-term Growth; Recent pullbacks create a buying opportunity.\n• 86Research is bullish on TIGR’s capability to continue to gain market share from traditional brokers. The strategic focus and operating efficiency of Internet companies give advantages to TIGR, such as lower pricing and better user experience in retail brokerage services. Moreover, TIGR provides more variety than most traditional brokers, enabling retail investors to trade securities in several markets in one app and one account.\n• Non-commission revenues are ramping up quickly. Interest income will keep growing as more consolidated account (CA) account users will adopt self-funded financing services provided by TIGR. Their analysis suggests that the net interest spread of the financing services for CA account users was much higher than the rate of financing service for fully disclosed (FD) account users. In addition, the business development in investment banking and wealth management services are expected to contribute meaningful revenues.\n• International expansion creates a new story. TIGR has ramped up its global expansion from 3Q20, mainly targeting Singapore and US markets. Singapore has more than 1 mln addressable individual investors, about half of the market size in HK. The US market has nearly 100 mln retail investors, with total assets of approximately $50 trillion. Although facing challenges in terms of culture, regulatory environment and competition, 86Research is positive that TIGR will capture more growth in its two promising markets.\n• TIGR’s stock price has been volatile. 86Research recommends investors buy on the dip. Recent stock market volatility will impact its financial performance but won‘t change the long-term growth story, in their view. The company continues to gain market share in retail brokerage services and develop non-commission businesses, such as margin financing, wealth management, order flows, etc.86Research is confident such growth can offset the cyclical impact from a long-term perspective.\n• HK license is a near-term catalyst. TIGR is expected to get a brokerage license in HK as soon as this year, which will enable it to run market campaigns and acquire users in the region. As a registered brokerage firm, TIGR can also build connections with banks to provide IPO subscriptions and financing services in Hong Kong and support the development of margin financing business.","news_type":1},"isVote":1,"tweetType":1,"viewCount":297,"authorTweetTopStatus":1,"verified":2,"comments":[],"imageCount":0,"langContent":"CN","totalScore":0}],"hots":[{"id":690267465,"gmtCreate":1639670593948,"gmtModify":1639670594054,"author":{"id":"3554709228084997","authorId":"3554709228084997","name":"Tamilan","avatar":"https://static.tigerbbs.com/f9c0c40895d679ae9116bc66aa2adca3","crmLevel":2,"crmLevelSwitch":0,"followedFlag":false},"themes":[],"htmlText":"<a href=\"https://laohu8.com/S/SOFI\">$SoFi Technologies Inc.(SOFI)$</a>investors sold lot of shares in recent day.. check the company profile column&nbsp;","listText":"<a href=\"https://laohu8.com/S/SOFI\">$SoFi Technologies Inc.(SOFI)$</a>investors sold lot of shares in recent day.. check the company profile column&nbsp;","text":"$SoFi Technologies Inc.(SOFI)$investors sold lot of shares in recent day.. check the company profile column","images":[],"top":1,"highlighted":1,"essential":1,"paper":1,"likeSize":13,"commentSize":2,"repostSize":1,"link":"https://laohu8.com/post/690267465","isVote":1,"tweetType":1,"viewCount":1814,"authorTweetTopStatus":1,"verified":2,"comments":[],"imageCount":0,"langContent":"CN","totalScore":0},{"id":606003855,"gmtCreate":1638797908762,"gmtModify":1638799926288,"author":{"id":"3554709228084997","authorId":"3554709228084997","name":"Tamilan","avatar":"https://static.tigerbbs.com/f9c0c40895d679ae9116bc66aa2adca3","crmLevel":2,"crmLevelSwitch":0,"followedFlag":false},"themes":[],"htmlText":"As Clover Health Investments, Corp.'s market cap (NASDAQ:CLOV) drops to US$2.0b, insiders might be questioning their decision to buy earlier this year","listText":"As Clover Health Investments, Corp.'s market cap (NASDAQ:CLOV) drops to US$2.0b, insiders might be questioning their decision to buy earlier this year","text":"As Clover Health Investments, Corp.'s market cap (NASDAQ:CLOV) drops to US$2.0b, insiders might be questioning their decision to buy earlier this year","images":[],"top":1,"highlighted":1,"essential":1,"paper":1,"likeSize":3,"commentSize":0,"repostSize":0,"link":"https://laohu8.com/post/606003855","repostId":"1147959487","repostType":2,"repost":{"id":"1147959487","pubTimestamp":1638793685,"share":"https://www.laohu8.com/m/news/1147959487?lang=&edition=full","pubTime":"2021-12-06 20:28","market":"us","language":"en","title":"With Hope and Hype Gone, Clover Health Will Now Remain a Penny Stock","url":"https://stock-news.laohu8.com/highlight/detail?id=1147959487","media":"InvestorPlace","summary":"As it struggles to control costs, don't expect continued top-line growth to fuel a recovery for CLOV","content":"<p>As it struggles to control costs, don't expect continued top-line growth to fuel a recovery for CLOV stock</p>\n<p>I may have&nbsp;called it one ahead of time. But now, after it’s slipped below $5 per share,<b>Clover Health</b>(NASDAQ:<b><u>CLOV</u></b>) is officially a penny stock. Sure, this label says little about the prospects for CLOV stock, or its underlying business. Yet there is one key takeaway. The hope and hype surrounding this online-based provider of Medicare Advantage plans is officially gone.</p>\n<p>As you likely recall, there have been several waves of enthusiasm surrounding this stock over the past year. First, after this special purpose acquisition company (SPAC) deSPACed in late 2020, investors bid it up. Given the success of other blank-check companies backed by Chamath Palihapitiya, this made sense.</p>\n<p>Then, after falling sharply between February and May, due to a&nbsp;“short report”&nbsp;and the&nbsp;“SPAC wipeout,”the stock became hot once again.</p>\n<p>This time, as a meme stock/short-squeeze play going parabolic and hitting new highs, Clover almost seemed set to join the ranks of&nbsp;<b>AMC Entertainment</b>(NYSE:<b><u>AMC</u></b>) and&nbsp;<b>GameStop</b>(NYSE:<b><u>GME</u></b>). But it didn’t. After June, it steadily became less of a squeeze play. Over the past six months, its short interest has gone from off-the-charts, to just&nbsp;7.6% of outstanding float.</p>\n<p>Today, with conversation about it on&nbsp;<b>Reddit’s</b><i>r/WallStreetsBets</i>&nbsp;subreddit&nbsp;well subdued fro what it once was, there’s only one path for shares out of their current penny stock status. Unfortunately, it’s a long one.</p>\n<p><b>Why CLOV Stock Fell Below $5 Per Share</b></p>\n<p>You can try to argue that Clover Health’s move to below $5 per share is due solely to market volatility. News of Covid-19’s Omicron variant, plus hawkish remarks from the Federal Reserve, have caused&nbsp;stocks across-the-board to move lower.</p>\n<p>But even before the latest overall dip in the market, CLOV stock was already heading south. Blame that on its latest quarterly earnings report, and&nbsp;sell side’s pessimism about its profitability&nbsp;timeline. Plus, as my&nbsp;<i>InvestorPlace</i>&nbsp;colleague Joel Baglole discussed on Nov. 18, there’s its recent dilutive&nbsp;$300 million secondary offering.</p>\n<p>On top of this, news of&nbsp; a&nbsp;shareholder lawsuit,due to Clover allegedly not disclosing the open Department of Justice (DOJ) investigation of it, which was one of the key bombshells from the above-mentioned short report. This grab bag of company-specific developments came on top of another key negative for the stock. That would be its waning appeal among the meme crowd. After several failed attempts to send it “to the moon” once more, Reddit traders have moved on.</p>\n<p>Put all these factors together, and it is clear why Clover now finds itself in the bargain basement.</p>\n<p>Yet, there is a silver lining. If it can get its operating costs under control, it will then start moving again in the right direction. The problem? For now, there’s little to suggest that’s soon set to happen.</p>\n<p><b>Only Cheap if You Assume Profitability Is Imminent</b></p>\n<p>Yes, at the current CLOV stock price (around $4.47 per share), it’s obviously not as pricey as it was at $10, $15, $20 or even $28.85 per share. Trading for less than 1x projected sales for 2022, this “disruptor” now trades at a forward valuation more in-line with its old-school peers.</p>\n<p>Furthermore, as my<i>InvestorPlace</i>colleague Dana Blankenhorn recently argued, if Clover managed to bring its margins up on par with&nbsp;<b>UnitedHealth Group</b>&nbsp;(NYSE:<b><u>UNH</u></b>) by next year, shares would be selling for just&nbsp;15x forward earnings. Unfortunately, bringing up margins is easier said than done.</p>\n<p>To achieve this, several things need to play out. First, Clover’s thesis that its very high&nbsp;medical cost ratio(MCR) is “transitory,” and a product of increased healthcare usage due to the pandemic recovery, needs to prove true. If a few quarters from now, when things have normalized post-Covid, the company is still paying out more in claims than it’s taking in as premiums? It’s going to be much harder for it to blame the virus for its problems.</p>\n<p>Second, even if it brings its MCR down to 85% (the bare minimum it needs to spend each year), it will need to really ramp up sales to cover its fixed overhead costs. Based on its SG&amp;A expenses last quarter ($119.1 million), its annual overhead is around $476.4 million. If it managed to achieve gross margins of 15%, it would need to generate at least $3.17 billion in revenue next year. Sell-side projections call for&nbsp;between $2.48 billion and $2.92 billion&nbsp;in revenue next year.</p>\n<p><b>Bottom Line on Clover</b></p>\n<p>I concede that it’s not impossible for Clover to one day become profitable. Assuming it continues to grow its revenues by high double-digits.&nbsp; The issue is with the timeline. Between now and when it gets out of the red, it could stay stuck at present levels, as more dilutive secondary offerings (to cover cash burn/fund growth) impact its ability to bounce back.</p>\n<p>Likely to languish at or below $5 per share for a while, skip out for now with CLOV stock.</p>","source":"lsy1606302653667","collect":0,"html":"<!DOCTYPE html>\n<html>\n<head>\n<meta http-equiv=\"Content-Type\" content=\"text/html; charset=utf-8\" />\n<meta name=\"viewport\" content=\"width=device-width,initial-scale=1.0,minimum-scale=1.0,maximum-scale=1.0,user-scalable=no\"/>\n<meta name=\"format-detection\" content=\"telephone=no,email=no,address=no\" />\n<title>With Hope and Hype Gone, Clover Health Will Now Remain a Penny Stock</title>\n<style type=\"text/css\">\na,abbr,acronym,address,applet,article,aside,audio,b,big,blockquote,body,canvas,caption,center,cite,code,dd,del,details,dfn,div,dl,dt,\nem,embed,fieldset,figcaption,figure,footer,form,h1,h2,h3,h4,h5,h6,header,hgroup,html,i,iframe,img,ins,kbd,label,legend,li,mark,menu,nav,\nobject,ol,output,p,pre,q,ruby,s,samp,section,small,span,strike,strong,sub,summary,sup,table,tbody,td,tfoot,th,thead,time,tr,tt,u,ul,var,video{ font:inherit;margin:0;padding:0;vertical-align:baseline;border:0 }\nbody{ font-size:16px; line-height:1.5; color:#999; background:transparent; }\n.wrapper{ overflow:hidden;word-break:break-all;padding:10px; }\nh1,h2{ font-weight:normal; line-height:1.35; margin-bottom:.6em; }\nh3,h4,h5,h6{ line-height:1.35; margin-bottom:1em; }\nh1{ font-size:24px; }\nh2{ font-size:20px; }\nh3{ font-size:18px; }\nh4{ font-size:16px; }\nh5{ font-size:14px; }\nh6{ font-size:12px; }\np,ul,ol,blockquote,dl,table{ margin:1.2em 0; }\nul,ol{ margin-left:2em; }\nul{ list-style:disc; }\nol{ list-style:decimal; }\nli,li p{ margin:10px 0;}\nimg{ max-width:100%;display:block;margin:0 auto 1em; }\nblockquote{ color:#B5B2B1; border-left:3px solid #aaa; padding:1em; }\nstrong,b{font-weight:bold;}\nem,i{font-style:italic;}\ntable{ width:100%;border-collapse:collapse;border-spacing:1px;margin:1em 0;font-size:.9em; }\nth,td{ padding:5px;text-align:left;border:1px solid #aaa; }\nth{ font-weight:bold;background:#5d5d5d; }\n.symbol-link{font-weight:bold;}\n/* header{ border-bottom:1px solid #494756; } */\n.title{ margin:0 0 8px;line-height:1.3;color:#ddd; }\n.meta {color:#5e5c6d;font-size:13px;margin:0 0 .5em; }\na{text-decoration:none; color:#2a4b87;}\n.meta .head { display: inline-block; overflow: hidden}\n.head .h-thumb { width: 30px; height: 30px; margin: 0; padding: 0; border-radius: 50%; float: left;}\n.head .h-content { margin: 0; padding: 0 0 0 9px; float: left;}\n.head .h-name {font-size: 13px; color: #eee; margin: 0;}\n.head .h-time {font-size: 11px; color: #7E829C; margin: 0;line-height: 11px;}\n.small {font-size: 12.5px; display: inline-block; transform: scale(0.9); -webkit-transform: scale(0.9); transform-origin: left; -webkit-transform-origin: left;}\n.smaller {font-size: 12.5px; display: inline-block; transform: scale(0.8); -webkit-transform: scale(0.8); transform-origin: left; -webkit-transform-origin: left;}\n.bt-text {font-size: 12px;margin: 1.5em 0 0 0}\n.bt-text p {margin: 0}\n</style>\n</head>\n<body>\n<div class=\"wrapper\">\n<header>\n<h2 class=\"title\">\nWith Hope and Hype Gone, Clover Health Will Now Remain a Penny Stock\n</h2>\n\n<h4 class=\"meta\">\n\n\n2021-12-06 20:28 GMT+8&nbsp;&nbsp;&nbsp;<a href=https://investorplace.com/2021/12/clov-stock-now-penny-stock-expect-it-to-stay-that-way/><strong>InvestorPlace</strong></a>\n\n\n</h4>\n\n</header>\n<article>\n<div>\n<p>As it struggles to control costs, don't expect continued top-line growth to fuel a recovery for CLOV stock\nI may have called it one ahead of time. But now, after it’s slipped below $5 per share,Clover...</p>\n\n<a href=\"https://investorplace.com/2021/12/clov-stock-now-penny-stock-expect-it-to-stay-that-way/\">Web Link</a>\n\n</div>\n\n\n</article>\n</div>\n</body>\n</html>\n","type":0,"thumbnail":"","relate_stocks":{"CLOV":"Clover Health Corp"},"source_url":"https://investorplace.com/2021/12/clov-stock-now-penny-stock-expect-it-to-stay-that-way/","is_english":true,"share_image_url":"https://static.laohu8.com/e9f99090a1c2ed51c021029395664489","article_id":"1147959487","content_text":"As it struggles to control costs, don't expect continued top-line growth to fuel a recovery for CLOV stock\nI may have called it one ahead of time. But now, after it’s slipped below $5 per share,Clover Health(NASDAQ:CLOV) is officially a penny stock. Sure, this label says little about the prospects for CLOV stock, or its underlying business. Yet there is one key takeaway. The hope and hype surrounding this online-based provider of Medicare Advantage plans is officially gone.\nAs you likely recall, there have been several waves of enthusiasm surrounding this stock over the past year. First, after this special purpose acquisition company (SPAC) deSPACed in late 2020, investors bid it up. Given the success of other blank-check companies backed by Chamath Palihapitiya, this made sense.\nThen, after falling sharply between February and May, due to a “short report” and the “SPAC wipeout,”the stock became hot once again.\nThis time, as a meme stock/short-squeeze play going parabolic and hitting new highs, Clover almost seemed set to join the ranks of AMC Entertainment(NYSE:AMC) and GameStop(NYSE:GME). But it didn’t. After June, it steadily became less of a squeeze play. Over the past six months, its short interest has gone from off-the-charts, to just 7.6% of outstanding float.\nToday, with conversation about it on Reddit’sr/WallStreetsBets subreddit well subdued fro what it once was, there’s only one path for shares out of their current penny stock status. Unfortunately, it’s a long one.\nWhy CLOV Stock Fell Below $5 Per Share\nYou can try to argue that Clover Health’s move to below $5 per share is due solely to market volatility. News of Covid-19’s Omicron variant, plus hawkish remarks from the Federal Reserve, have caused stocks across-the-board to move lower.\nBut even before the latest overall dip in the market, CLOV stock was already heading south. Blame that on its latest quarterly earnings report, and sell side’s pessimism about its profitability timeline. Plus, as my InvestorPlace colleague Joel Baglole discussed on Nov. 18, there’s its recent dilutive $300 million secondary offering.\nOn top of this, news of  a shareholder lawsuit,due to Clover allegedly not disclosing the open Department of Justice (DOJ) investigation of it, which was one of the key bombshells from the above-mentioned short report. This grab bag of company-specific developments came on top of another key negative for the stock. That would be its waning appeal among the meme crowd. After several failed attempts to send it “to the moon” once more, Reddit traders have moved on.\nPut all these factors together, and it is clear why Clover now finds itself in the bargain basement.\nYet, there is a silver lining. If it can get its operating costs under control, it will then start moving again in the right direction. The problem? For now, there’s little to suggest that’s soon set to happen.\nOnly Cheap if You Assume Profitability Is Imminent\nYes, at the current CLOV stock price (around $4.47 per share), it’s obviously not as pricey as it was at $10, $15, $20 or even $28.85 per share. Trading for less than 1x projected sales for 2022, this “disruptor” now trades at a forward valuation more in-line with its old-school peers.\nFurthermore, as myInvestorPlacecolleague Dana Blankenhorn recently argued, if Clover managed to bring its margins up on par with UnitedHealth Group (NYSE:UNH) by next year, shares would be selling for just 15x forward earnings. Unfortunately, bringing up margins is easier said than done.\nTo achieve this, several things need to play out. First, Clover’s thesis that its very high medical cost ratio(MCR) is “transitory,” and a product of increased healthcare usage due to the pandemic recovery, needs to prove true. If a few quarters from now, when things have normalized post-Covid, the company is still paying out more in claims than it’s taking in as premiums? It’s going to be much harder for it to blame the virus for its problems.\nSecond, even if it brings its MCR down to 85% (the bare minimum it needs to spend each year), it will need to really ramp up sales to cover its fixed overhead costs. Based on its SG&A expenses last quarter ($119.1 million), its annual overhead is around $476.4 million. If it managed to achieve gross margins of 15%, it would need to generate at least $3.17 billion in revenue next year. Sell-side projections call for between $2.48 billion and $2.92 billion in revenue next year.\nBottom Line on Clover\nI concede that it’s not impossible for Clover to one day become profitable. Assuming it continues to grow its revenues by high double-digits.  The issue is with the timeline. Between now and when it gets out of the red, it could stay stuck at present levels, as more dilutive secondary offerings (to cover cash burn/fund growth) impact its ability to bounce back.\nLikely to languish at or below $5 per share for a while, skip out for now with CLOV stock.","news_type":1},"isVote":1,"tweetType":1,"viewCount":461,"authorTweetTopStatus":1,"verified":2,"comments":[],"imageCount":0,"langContent":"CN","totalScore":0},{"id":865010843,"gmtCreate":1632923246605,"gmtModify":1632923246672,"author":{"id":"3554709228084997","authorId":"3554709228084997","name":"Tamilan","avatar":"https://static.tigerbbs.com/f9c0c40895d679ae9116bc66aa2adca3","crmLevel":2,"crmLevelSwitch":0,"followedFlag":false},"themes":[],"htmlText":"My one down 20% but thus is still fake news&nbsp;","listText":"My one down 20% but thus is still fake news&nbsp;","text":"My one down 20% but thus is still fake news","images":[],"top":1,"highlighted":1,"essential":1,"paper":1,"likeSize":2,"commentSize":0,"repostSize":0,"link":"https://laohu8.com/post/865010843","repostId":"1169529009","repostType":2,"repost":{"id":"1169529009","weMediaInfo":{"introduction":"Providing stock market headlines, business news, financials and earnings ","home_visible":1,"media_name":"Tiger Newspress","id":"1079075236","head_image":"https://static.tigerbbs.com/8274c5b9d4c2852bfb1c4d6ce16c68ba"},"pubTimestamp":1632904196,"share":"https://www.laohu8.com/m/news/1169529009?lang=&edition=full","pubTime":"2021-09-29 16:29","market":"us","language":"en","title":"86Research initiates coverage on TIGR with a BUY rating","url":"https://stock-news.laohu8.com/highlight/detail?id=1169529009","media":"Tiger Newspress","summary":"• 86Research initiates coverage on TIGR with a BUY rating. Growing demand for cross-border stock inv","content":"<p>• 86Research initiates coverage on TIGR with a BUY rating. Growing demand for cross-border stock investment in China and rising internet-based retail brokerage services globally&nbsp;together support strong industry fundamentals. TIGR, an early mover in the internet brokerage sector, significantly outperforms traditional brokers by providing better services for retail investors. Their&nbsp;price target of US$21 per ADS implies 83%&nbsp;upside&nbsp;potential&nbsp;from&nbsp;the&nbsp;latest&nbsp;market&nbsp;close&nbsp;price,&nbsp;despite&nbsp;possible&nbsp;sector-widevolatilityinChineseADRs.</p>\n<p>•&nbsp;86Research forecasts TIGR’s net revenues will reach US&nbsp;$668 mln in 2024, giving it a 4-yr CAGR of 51%. According to their projection, the number of customers with deposits on TIGR will reach 1.7 mln by the end of 2024. The total AUM and financing balance will exceed US$103 bln and US$5.5 bln, respectively. Trading volumes on TIGR are forecast to reach US$1,338 bln in 2024. 86Research expects the commission rate will remain largely flat. More derivatives trades will partially offset the negative impact from price competition. 86Research thinks the blended interest rate will&nbsp;decline&nbsp;due&nbsp;to&nbsp;the&nbsp;mix&nbsp;change&nbsp;of&nbsp;financing&nbsp;activities&nbsp;on&nbsp;the&nbsp;platform.</p>\n<p>• 86Research&nbsp;derives&nbsp;their&nbsp;US$21&nbsp;price&nbsp;target&nbsp;based&nbsp;on&nbsp;a&nbsp;20x&nbsp;2024E&nbsp;P/E&nbsp;multiple&nbsp;and&nbsp;13%&nbsp;2-yr&nbsp;discount&nbsp;rate.&nbsp;The&nbsp;PT&nbsp;implies&nbsp;13.8x/11.7x/8.4x&nbsp;2021E/2022E/2023E&nbsp;forward&nbsp;P/B&nbsp;multiples,&nbsp;reflecting&nbsp;a&nbsp;premium&nbsp;to&nbsp;global&nbsp;peers.&nbsp;HK&nbsp;license&nbsp;approval,&nbsp;progress&nbsp;in&nbsp;international&nbsp;expansion and US self-clearing are the key catalysts in the near term, while regulatory and macro uncertainties are the main investment risks. 86Research recommends investors buy the stock on recent pullbacks which have resulted from weak market sentiment. 86’s View on TIGR: BUY; PT$21/ADS; A Rising China-Based Internet Brokerage Platform; Global Expansion To Drive Long-term Growth; Recent pullbacks create a buying opportunity.</p>\n<p>• 86Research is bullish on TIGR’s capability to continue to gain market share from traditional brokers. The strategic focus and operating efficiency of Internet companies give advantages to TIGR, such as lower pricing and better user experience in retail brokerage services. Moreover, TIGR provides more variety than most traditional brokers, enabling retail investors to trade securities in several markets in one app&nbsp;and&nbsp;one&nbsp;account.</p>\n<p>• Non-commission revenues are ramping up quickly. Interest income will keep growing as more consolidated account (CA) account users will adopt self-funded financing services provided by TIGR. Their analysis suggests that the net interest spread of the financing services for CA account users was much higher than the rate of financing service for fully disclosed (FD) account users. In addition, the business&nbsp;development&nbsp;in&nbsp;investment&nbsp;banking&nbsp;and&nbsp;wealth&nbsp;management&nbsp;services&nbsp;are&nbsp;expected&nbsp;to&nbsp;contribute&nbsp;meaningful&nbsp;revenues.</p>\n<p>• International expansion creates a new story. TIGR has ramped up its global expansion from 3Q20, mainly targeting Singapore and US markets. Singapore has more than 1 mln addressable individual investors, about half of the market size in HK. The US market has nearly 100 mln retail investors, with total assets of approximately $50 trillion.&nbsp;Although&nbsp;facing&nbsp;challenges&nbsp;in&nbsp;terms&nbsp;of&nbsp;culture,&nbsp;regulatory&nbsp;environment&nbsp;and&nbsp;competition,&nbsp;86Research&nbsp;is&nbsp;positive&nbsp;that&nbsp;TIGR&nbsp;will&nbsp;capture&nbsp;more&nbsp;growth&nbsp;in&nbsp;its&nbsp;two&nbsp;promising&nbsp;markets.</p>\n<p>• TIGR’s stock price has been volatile. 86Research recommends investors buy on the dip. Recent stock market volatility will impact its financial performance but won‘t change the long-term growth story, in their view. The company continues to gain market share in retail brokerage services and develop non-commission businesses, such as margin financing, wealth management, order flows, etc.86Research&nbsp;is confident such growth&nbsp;can&nbsp;offset&nbsp;the&nbsp;cyclical&nbsp;impact&nbsp;from&nbsp;a&nbsp;long-term&nbsp;perspective.</p>\n<p>• HK license is a near-term catalyst. TIGR is expected to get a brokerage license in HK as soon as this year, which will enable it to run market campaigns and acquire users in the region. As a registered brokerage firm, TIGR&nbsp;can&nbsp;also&nbsp;build&nbsp;connections&nbsp;with&nbsp;banks to&nbsp;provide&nbsp;IPO&nbsp;subscriptions&nbsp;and&nbsp;financing&nbsp;services&nbsp;in&nbsp;Hong&nbsp;Kong&nbsp;and&nbsp;support&nbsp;the&nbsp;development&nbsp;of&nbsp;margin&nbsp;financing&nbsp;business.</p>","collect":0,"html":"<!DOCTYPE html>\n<html>\n<head>\n<meta http-equiv=\"Content-Type\" content=\"text/html; charset=utf-8\" />\n<meta name=\"viewport\" content=\"width=device-width,initial-scale=1.0,minimum-scale=1.0,maximum-scale=1.0,user-scalable=no\"/>\n<meta name=\"format-detection\" content=\"telephone=no,email=no,address=no\" />\n<title>86Research initiates coverage on TIGR with a BUY rating</title>\n<style type=\"text/css\">\na,abbr,acronym,address,applet,article,aside,audio,b,big,blockquote,body,canvas,caption,center,cite,code,dd,del,details,dfn,div,dl,dt,\nem,embed,fieldset,figcaption,figure,footer,form,h1,h2,h3,h4,h5,h6,header,hgroup,html,i,iframe,img,ins,kbd,label,legend,li,mark,menu,nav,\nobject,ol,output,p,pre,q,ruby,s,samp,section,small,span,strike,strong,sub,summary,sup,table,tbody,td,tfoot,th,thead,time,tr,tt,u,ul,var,video{ font:inherit;margin:0;padding:0;vertical-align:baseline;border:0 }\nbody{ font-size:16px; line-height:1.5; color:#999; background:transparent; }\n.wrapper{ overflow:hidden;word-break:break-all;padding:10px; }\nh1,h2{ font-weight:normal; line-height:1.35; margin-bottom:.6em; }\nh3,h4,h5,h6{ line-height:1.35; margin-bottom:1em; }\nh1{ font-size:24px; }\nh2{ font-size:20px; }\nh3{ font-size:18px; }\nh4{ font-size:16px; }\nh5{ font-size:14px; }\nh6{ font-size:12px; }\np,ul,ol,blockquote,dl,table{ margin:1.2em 0; }\nul,ol{ margin-left:2em; }\nul{ list-style:disc; }\nol{ list-style:decimal; }\nli,li p{ margin:10px 0;}\nimg{ max-width:100%;display:block;margin:0 auto 1em; }\nblockquote{ color:#B5B2B1; border-left:3px solid #aaa; padding:1em; }\nstrong,b{font-weight:bold;}\nem,i{font-style:italic;}\ntable{ width:100%;border-collapse:collapse;border-spacing:1px;margin:1em 0;font-size:.9em; }\nth,td{ padding:5px;text-align:left;border:1px solid #aaa; }\nth{ font-weight:bold;background:#5d5d5d; }\n.symbol-link{font-weight:bold;}\n/* header{ border-bottom:1px solid #494756; } */\n.title{ margin:0 0 8px;line-height:1.3;color:#ddd; }\n.meta {color:#5e5c6d;font-size:13px;margin:0 0 .5em; }\na{text-decoration:none; color:#2a4b87;}\n.meta .head { display: inline-block; overflow: hidden}\n.head .h-thumb { width: 30px; height: 30px; margin: 0; padding: 0; border-radius: 50%; float: left;}\n.head .h-content { margin: 0; padding: 0 0 0 9px; float: left;}\n.head .h-name {font-size: 13px; color: #eee; margin: 0;}\n.head .h-time {font-size: 11px; color: #7E829C; margin: 0;line-height: 11px;}\n.small {font-size: 12.5px; display: inline-block; transform: scale(0.9); -webkit-transform: scale(0.9); transform-origin: left; -webkit-transform-origin: left;}\n.smaller {font-size: 12.5px; display: inline-block; transform: scale(0.8); -webkit-transform: scale(0.8); transform-origin: left; -webkit-transform-origin: left;}\n.bt-text {font-size: 12px;margin: 1.5em 0 0 0}\n.bt-text p {margin: 0}\n</style>\n</head>\n<body>\n<div class=\"wrapper\">\n<header>\n<h2 class=\"title\">\n86Research initiates coverage on TIGR with a BUY rating\n</h2>\n\n<h4 class=\"meta\">\n\n\n<a class=\"head\" href=\"https://laohu8.com/wemedia/1079075236\">\n\n\n<div class=\"h-thumb\" style=\"background-image:url(https://static.tigerbbs.com/8274c5b9d4c2852bfb1c4d6ce16c68ba);background-size:cover;\"></div>\n\n<div class=\"h-content\">\n<p class=\"h-name\">Tiger Newspress </p>\n<p class=\"h-time\">2021-09-29 16:29</p>\n</div>\n\n</a>\n\n\n</h4>\n\n</header>\n<article>\n<p>• 86Research initiates coverage on TIGR with a BUY rating. Growing demand for cross-border stock investment in China and rising internet-based retail brokerage services globally&nbsp;together support strong industry fundamentals. TIGR, an early mover in the internet brokerage sector, significantly outperforms traditional brokers by providing better services for retail investors. Their&nbsp;price target of US$21 per ADS implies 83%&nbsp;upside&nbsp;potential&nbsp;from&nbsp;the&nbsp;latest&nbsp;market&nbsp;close&nbsp;price,&nbsp;despite&nbsp;possible&nbsp;sector-widevolatilityinChineseADRs.</p>\n<p>•&nbsp;86Research forecasts TIGR’s net revenues will reach US&nbsp;$668 mln in 2024, giving it a 4-yr CAGR of 51%. According to their projection, the number of customers with deposits on TIGR will reach 1.7 mln by the end of 2024. The total AUM and financing balance will exceed US$103 bln and US$5.5 bln, respectively. Trading volumes on TIGR are forecast to reach US$1,338 bln in 2024. 86Research expects the commission rate will remain largely flat. More derivatives trades will partially offset the negative impact from price competition. 86Research thinks the blended interest rate will&nbsp;decline&nbsp;due&nbsp;to&nbsp;the&nbsp;mix&nbsp;change&nbsp;of&nbsp;financing&nbsp;activities&nbsp;on&nbsp;the&nbsp;platform.</p>\n<p>• 86Research&nbsp;derives&nbsp;their&nbsp;US$21&nbsp;price&nbsp;target&nbsp;based&nbsp;on&nbsp;a&nbsp;20x&nbsp;2024E&nbsp;P/E&nbsp;multiple&nbsp;and&nbsp;13%&nbsp;2-yr&nbsp;discount&nbsp;rate.&nbsp;The&nbsp;PT&nbsp;implies&nbsp;13.8x/11.7x/8.4x&nbsp;2021E/2022E/2023E&nbsp;forward&nbsp;P/B&nbsp;multiples,&nbsp;reflecting&nbsp;a&nbsp;premium&nbsp;to&nbsp;global&nbsp;peers.&nbsp;HK&nbsp;license&nbsp;approval,&nbsp;progress&nbsp;in&nbsp;international&nbsp;expansion and US self-clearing are the key catalysts in the near term, while regulatory and macro uncertainties are the main investment risks. 86Research recommends investors buy the stock on recent pullbacks which have resulted from weak market sentiment. 86’s View on TIGR: BUY; PT$21/ADS; A Rising China-Based Internet Brokerage Platform; Global Expansion To Drive Long-term Growth; Recent pullbacks create a buying opportunity.</p>\n<p>• 86Research is bullish on TIGR’s capability to continue to gain market share from traditional brokers. The strategic focus and operating efficiency of Internet companies give advantages to TIGR, such as lower pricing and better user experience in retail brokerage services. Moreover, TIGR provides more variety than most traditional brokers, enabling retail investors to trade securities in several markets in one app&nbsp;and&nbsp;one&nbsp;account.</p>\n<p>• Non-commission revenues are ramping up quickly. Interest income will keep growing as more consolidated account (CA) account users will adopt self-funded financing services provided by TIGR. Their analysis suggests that the net interest spread of the financing services for CA account users was much higher than the rate of financing service for fully disclosed (FD) account users. In addition, the business&nbsp;development&nbsp;in&nbsp;investment&nbsp;banking&nbsp;and&nbsp;wealth&nbsp;management&nbsp;services&nbsp;are&nbsp;expected&nbsp;to&nbsp;contribute&nbsp;meaningful&nbsp;revenues.</p>\n<p>• International expansion creates a new story. TIGR has ramped up its global expansion from 3Q20, mainly targeting Singapore and US markets. Singapore has more than 1 mln addressable individual investors, about half of the market size in HK. The US market has nearly 100 mln retail investors, with total assets of approximately $50 trillion.&nbsp;Although&nbsp;facing&nbsp;challenges&nbsp;in&nbsp;terms&nbsp;of&nbsp;culture,&nbsp;regulatory&nbsp;environment&nbsp;and&nbsp;competition,&nbsp;86Research&nbsp;is&nbsp;positive&nbsp;that&nbsp;TIGR&nbsp;will&nbsp;capture&nbsp;more&nbsp;growth&nbsp;in&nbsp;its&nbsp;two&nbsp;promising&nbsp;markets.</p>\n<p>• TIGR’s stock price has been volatile. 86Research recommends investors buy on the dip. Recent stock market volatility will impact its financial performance but won‘t change the long-term growth story, in their view. The company continues to gain market share in retail brokerage services and develop non-commission businesses, such as margin financing, wealth management, order flows, etc.86Research&nbsp;is confident such growth&nbsp;can&nbsp;offset&nbsp;the&nbsp;cyclical&nbsp;impact&nbsp;from&nbsp;a&nbsp;long-term&nbsp;perspective.</p>\n<p>• HK license is a near-term catalyst. TIGR is expected to get a brokerage license in HK as soon as this year, which will enable it to run market campaigns and acquire users in the region. As a registered brokerage firm, TIGR&nbsp;can&nbsp;also&nbsp;build&nbsp;connections&nbsp;with&nbsp;banks to&nbsp;provide&nbsp;IPO&nbsp;subscriptions&nbsp;and&nbsp;financing&nbsp;services&nbsp;in&nbsp;Hong&nbsp;Kong&nbsp;and&nbsp;support&nbsp;the&nbsp;development&nbsp;of&nbsp;margin&nbsp;financing&nbsp;business.</p>\n\n</article>\n</div>\n</body>\n</html>\n","type":0,"thumbnail":"","relate_stocks":{"TIGR":"老虎证券"},"is_english":true,"share_image_url":"https://static.laohu8.com/e9f99090a1c2ed51c021029395664489","article_id":"1169529009","content_text":"• 86Research initiates coverage on TIGR with a BUY rating. Growing demand for cross-border stock investment in China and rising internet-based retail brokerage services globally together support strong industry fundamentals. TIGR, an early mover in the internet brokerage sector, significantly outperforms traditional brokers by providing better services for retail investors. Their price target of US$21 per ADS implies 83% upside potential from the latest market close price, despite possible sector-widevolatilityinChineseADRs.\n• 86Research forecasts TIGR’s net revenues will reach US $668 mln in 2024, giving it a 4-yr CAGR of 51%. According to their projection, the number of customers with deposits on TIGR will reach 1.7 mln by the end of 2024. The total AUM and financing balance will exceed US$103 bln and US$5.5 bln, respectively. Trading volumes on TIGR are forecast to reach US$1,338 bln in 2024. 86Research expects the commission rate will remain largely flat. More derivatives trades will partially offset the negative impact from price competition. 86Research thinks the blended interest rate will decline due to the mix change of financing activities on the platform.\n• 86Research derives their US$21 price target based on a 20x 2024E P/E multiple and 13% 2-yr discount rate. The PT implies 13.8x/11.7x/8.4x 2021E/2022E/2023E forward P/B multiples, reflecting a premium to global peers. HK license approval, progress in international expansion and US self-clearing are the key catalysts in the near term, while regulatory and macro uncertainties are the main investment risks. 86Research recommends investors buy the stock on recent pullbacks which have resulted from weak market sentiment. 86’s View on TIGR: BUY; PT$21/ADS; A Rising China-Based Internet Brokerage Platform; Global Expansion To Drive Long-term Growth; Recent pullbacks create a buying opportunity.\n• 86Research is bullish on TIGR’s capability to continue to gain market share from traditional brokers. The strategic focus and operating efficiency of Internet companies give advantages to TIGR, such as lower pricing and better user experience in retail brokerage services. Moreover, TIGR provides more variety than most traditional brokers, enabling retail investors to trade securities in several markets in one app and one account.\n• Non-commission revenues are ramping up quickly. Interest income will keep growing as more consolidated account (CA) account users will adopt self-funded financing services provided by TIGR. Their analysis suggests that the net interest spread of the financing services for CA account users was much higher than the rate of financing service for fully disclosed (FD) account users. In addition, the business development in investment banking and wealth management services are expected to contribute meaningful revenues.\n• International expansion creates a new story. TIGR has ramped up its global expansion from 3Q20, mainly targeting Singapore and US markets. Singapore has more than 1 mln addressable individual investors, about half of the market size in HK. The US market has nearly 100 mln retail investors, with total assets of approximately $50 trillion. Although facing challenges in terms of culture, regulatory environment and competition, 86Research is positive that TIGR will capture more growth in its two promising markets.\n• TIGR’s stock price has been volatile. 86Research recommends investors buy on the dip. Recent stock market volatility will impact its financial performance but won‘t change the long-term growth story, in their view. The company continues to gain market share in retail brokerage services and develop non-commission businesses, such as margin financing, wealth management, order flows, etc.86Research is confident such growth can offset the cyclical impact from a long-term perspective.\n• HK license is a near-term catalyst. TIGR is expected to get a brokerage license in HK as soon as this year, which will enable it to run market campaigns and acquire users in the region. As a registered brokerage firm, TIGR can also build connections with banks to provide IPO subscriptions and financing services in Hong Kong and support the development of margin financing business.","news_type":1},"isVote":1,"tweetType":1,"viewCount":297,"authorTweetTopStatus":1,"verified":2,"comments":[],"imageCount":0,"langContent":"CN","totalScore":0},{"id":606003908,"gmtCreate":1638797893312,"gmtModify":1638799926250,"author":{"id":"3554709228084997","authorId":"3554709228084997","name":"Tamilan","avatar":"https://static.tigerbbs.com/f9c0c40895d679ae9116bc66aa2adca3","crmLevel":2,"crmLevelSwitch":0,"followedFlag":false},"themes":[],"htmlText":"<a target=\"_blank\" href=\"https://laohu8.com/S/CLOV\">$Clover Health Corp(CLOV)$</a> we all F***** up As Clover Health Investments, Corp.'s market cap (NASDAQ:CLOV) drops to US$2.0b, insiders might be questioning their decision to buy earlier this year","listText":"<a target=\"_blank\" href=\"https://laohu8.com/S/CLOV\">$Clover Health Corp(CLOV)$</a> we all F***** up As Clover Health Investments, Corp.'s market cap (NASDAQ:CLOV) drops to US$2.0b, insiders might be questioning their decision to buy earlier this year","text":"$Clover Health Corp(CLOV)$ we all F***** up As Clover Health Investments, Corp.'s market cap (NASDAQ:CLOV) drops to US$2.0b, insiders might be questioning their decision to buy earlier this year","images":[],"top":1,"highlighted":1,"essential":1,"paper":1,"likeSize":1,"commentSize":0,"repostSize":0,"link":"https://laohu8.com/post/606003908","isVote":1,"tweetType":1,"viewCount":693,"authorTweetTopStatus":1,"verified":2,"comments":[],"imageCount":0,"langContent":"CN","totalScore":0},{"id":694855893,"gmtCreate":1641914117538,"gmtModify":1641914117643,"author":{"id":"3554709228084997","authorId":"3554709228084997","name":"Tamilan","avatar":"https://static.tigerbbs.com/f9c0c40895d679ae9116bc66aa2adca3","crmLevel":2,"crmLevelSwitch":0,"followedFlag":false},"themes":[],"htmlText":"‌<a href=\"https://laohu8.com/S/HOFV\">$Hall of Fame Resort &amp; Entertainment(HOFV)$</a>‌insider buying...HOLD","listText":"‌<a href=\"https://laohu8.com/S/HOFV\">$Hall of Fame Resort &amp; Entertainment(HOFV)$</a>‌insider buying...HOLD","text":"‌$Hall of Fame Resort & Entertainment(HOFV)$‌insider buying...HOLD","images":[{"img":"https://static.tigerbbs.com/6ca7276796aa05d5c5ddb45f327b6416","width":"200","height":"200"}],"top":1,"highlighted":1,"essential":1,"paper":1,"likeSize":0,"commentSize":0,"repostSize":0,"link":"https://laohu8.com/post/694855893","isVote":1,"tweetType":1,"viewCount":161,"authorTweetTopStatus":1,"verified":2,"comments":[],"imageCount":1,"langContent":"CN","totalScore":0},{"id":690220149,"gmtCreate":1639670607410,"gmtModify":1639670607518,"author":{"id":"3554709228084997","authorId":"3554709228084997","name":"Tamilan","avatar":"https://static.tigerbbs.com/f9c0c40895d679ae9116bc66aa2adca3","crmLevel":2,"crmLevelSwitch":0,"followedFlag":false},"themes":[],"htmlText":"Great ariticle, would you like to share it?","listText":"Great ariticle, would you like to share it?","text":"Great ariticle, would you like to share it?","images":[],"top":1,"highlighted":1,"essential":1,"paper":1,"likeSize":0,"commentSize":0,"repostSize":0,"link":"https://laohu8.com/post/690220149","repostId":"690267465","repostType":1,"repost":{"id":690267465,"gmtCreate":1639670593948,"gmtModify":1639670594054,"author":{"id":"3554709228084997","authorId":"3554709228084997","name":"Tamilan","avatar":"https://static.tigerbbs.com/f9c0c40895d679ae9116bc66aa2adca3","crmLevel":2,"crmLevelSwitch":0,"followedFlag":false},"themes":[],"htmlText":"<a href=\"https://laohu8.com/S/SOFI\">$SoFi Technologies Inc.(SOFI)$</a>investors sold lot of shares in recent day.. check the company profile column&nbsp;","listText":"<a href=\"https://laohu8.com/S/SOFI\">$SoFi Technologies Inc.(SOFI)$</a>investors sold lot of shares in recent day.. check the company profile column&nbsp;","text":"$SoFi Technologies Inc.(SOFI)$investors sold lot of shares in recent day.. check the company profile column","images":[],"top":1,"highlighted":1,"essential":1,"paper":1,"likeSize":0,"commentSize":0,"repostSize":0,"link":"https://laohu8.com/post/690267465","isVote":1,"tweetType":1,"viewCount":0,"authorTweetTopStatus":1,"verified":2,"comments":[],"imageCount":0,"langContent":"CN","totalScore":0},"isVote":1,"tweetType":1,"viewCount":90,"authorTweetTopStatus":1,"verified":2,"comments":[],"imageCount":0,"langContent":"CN","totalScore":0},{"id":877210807,"gmtCreate":1637934743066,"gmtModify":1637934743066,"author":{"id":"3554709228084997","authorId":"3554709228084997","name":"Tamilan","avatar":"https://static.tigerbbs.com/f9c0c40895d679ae9116bc66aa2adca3","crmLevel":2,"crmLevelSwitch":0,"followedFlag":false},"themes":[],"htmlText":"<a target=\"_blank\" href=\"https://laohu8.com/S/SAVE\">$Spirit Airlines(SAVE)$</a> DOES NOT HAVE ANY FLIGHTS TO AFRICA , SO FEAR WILL MAKE MONEY","listText":"<a target=\"_blank\" href=\"https://laohu8.com/S/SAVE\">$Spirit Airlines(SAVE)$</a> DOES NOT HAVE ANY FLIGHTS TO AFRICA , SO FEAR WILL MAKE MONEY","text":"$Spirit Airlines(SAVE)$ DOES NOT HAVE ANY FLIGHTS TO AFRICA , SO FEAR WILL MAKE MONEY","images":[],"top":1,"highlighted":1,"essential":1,"paper":1,"likeSize":0,"commentSize":0,"repostSize":0,"link":"https://laohu8.com/post/877210807","isVote":1,"tweetType":1,"viewCount":500,"authorTweetTopStatus":1,"verified":2,"comments":[],"imageCount":0,"langContent":"CN","totalScore":0}],"lives":[]}